Dirk-Rolf Gieselmann

dentognostics GmbH develops testing devices for dental diseases. It is a technology provider of in-vitro diagnostics products, used to identify aMMP-8 for the analysis of collagenolytic activity in the oral cavity. The company was founded in 2000 and is headquartered in Jena, Germany.

Matrix Biotech AG engages in the holding and management of participating interests, patents, trademarks, and licenses in the biotechnology sector. The company was founded on May 6, 2010 and is headquartered in Bassersdorf, Switzerland.

dentognostics GmbH develops testing devices for dental diseases. It is a technology provider of in-vitro diagnostics products, used to identify aMMP-8 for the analysis of collagenolytic activity in the oral cavity. The company was founded in 2000 and is headquartered in Jena, Germany.

Matrix Biotech AG engages in the holding and management of participating interests, patents, trademarks, and licenses in the biotechnology sector. The company was founded on May 6, 2010 and is headquartered in Bassersdorf, Switzerland.

dentognostics GmbH develops testing devices for dental diseases. It is a technology provider of in-vitro diagnostics products, used to identify aMMP-8 for the analysis of collagenolytic activity in the oral cavity. The company was founded in 2000 and is headquartered in Jena, Germany.